معرفی
Professor Mark Good is Chair of the School of Psychology at Cardiff University, where he conducts extensive research on the medial temporal lobe and hippocampus in relation to memory function and neurodegenerative conditions. His academic credentials include a BSc and DPhil, and he has maintained an active research profile with publications spanning over three decades.
Good's research interests focus on understanding the role of the hippocampus and associated brain structures in memory processes, and how neurodegenerative conditions like Alzheimer's disease and frontotemporal dementia influence hippocampal function. His work primarily utilizes preclinical models of brain pathology, including genetic models of heritable neurodegenerative conditions. Current projects include assessment of configural and episodic-like memory, characterization of transgenic Alzheimer's disease models, investigation of dietary supplements for Alzheimer's pathology, assessment of novel antibody treatments, and studying cannabinoid receptors in memory disorders.
Analysis of his recent publications (2020-2025) reveals a strong focus on Alzheimer's disease models, with particular attention to amyloid pathology, hippocampal function, and potential therapeutic interventions. His work spans multiple disciplines including neuroscience, psychology, and molecular biology, with significant contributions to understanding the neural basis of cognitive impairment in neurodegenerative conditions. Many studies employ transgenic mouse models to investigate specific aspects of memory dysfunction and potential treatments.
Professor Good teaches biological psychology to level 2 undergraduate students, delivers a complete level 3 module on the neuroscience of learning and memory, and provides specialized lectures to neuroscience and medical students on preclinical models of Alzheimer's disease and higher cortical function. His teaching directly reflects his research expertise in cognitive neuroscience and neurodegenerative disorders.
His research team collaborates extensively with colleagues across neuroscience disciplines, investigating various aspects of cognitive impairment in neurodegenerative conditions. Current projects suggest active investigation of potential therapeutic approaches for Alzheimer's disease, including dietary interventions, probiotic effects, and novel antibody treatments targeting amyloid pathology.
